EDN1 and hypertensive disorder: The ET-1 system was found to be activated in sunitinib-treated rats [9]; its causal role in TKI-associated hypertension was proposed, since in rats treated with sunitinib, the increase in BP was prevented by Macitentant, which is an ET-1 receptor-specific blocker [10].